About Dylan Sammut
Dylan joined Irving Levin in October 2018 as a Research and Editorial Associate and is responsible for reporting on mergers and acquisitions in the healthcare sector. He graduated from Alfred University in May 2014 with a degree in English and Political Science. He currently lives in Bridgeport, CT with his fiancé and his overweight cat, Kimba, and in his free time he plays video games, reads, writes, and hikes on the weekends all year around.
by Dylan Sammut | Jun 9, 2020 9:46 am | Biotechnology
Gilead Sciences, Inc. (NASDAQ: GILD), just a few months after its $4.9 billion purchase of Forty Seven, Inc. (NASDAQ: FTSV), has signed a 10-year partnership agreement to co-develop and co-commercialize next generation cancer immunotherapy with Arcus Biosciences... Read More »
by Dylan Sammut | Jun 9, 2020 8:48 am | Healthcare Market Updates
The only way to go is up, right? April was the first full month after the World Health Organization declared the COVID-19 virus a pandemic on March 11, and you can see the impact in the healthcare M&A numbers. Even after adding deals that surfaced in later weeks,... Read More »
by Dylan Sammut | Jun 8, 2020 3:33 pm | Physician Medical Groups
Things are tough for physician medical groups, there’s no doubt about that. Since March 18, 2020, when the Centers for Medicare & Medicaid Services recommended that all elective, nonessential medical, surgical and dental procedures be delayed for the duration of... Read More »
by Dylan Sammut | Jun 8, 2020 10:07 am | Healthcare Market Updates
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our Deal Search Online database, which is updated daily to provide our subscribers with the most up-to-date... Read More »
by Dylan Sammut | Jun 1, 2020 4:13 pm | Managed Care
In late April, the Social Security and Medicare Trustees released two reports on the financial state of their respective programs, and you’ve probably guessed, the outlook is grim. Without accounting for the adverse economic or health consequences of COVID-19,... Read More »